New York Post
@nypost·2.4M subscribers·43.2K videos
Biden administration unveils first 10 drugs subject to Medicare price negotiations
Posted
August 29, 2023
Views
2,305
Likes
25
Comments
15
Engagement
1.74%
August 29, 2023
2,305
25
15
1.74%
Every word spoken in this episode is indexed. Type any phrase to jump straight to the moment it was said.
Type any word or phrase that may have been spoken. Click a result to seek the player to that exact moment.
Try a name, a topic, or a quoted line
See what was published immediately before and after this episode.
1:10Now PlayingThe Biden administration on Tuesday (August 29) released its list of 10 prescription medicines that will be subject to the first-ever price negotiations by the U.S. Medicare health program that covers 66 million people, with big-selling blood thinner Eliquis from Bristol Myers Squibb and Pfizer among them.
U.S President Joe Biden said in a statement that once implemented, the prices of negotiated drugs will decrease for up to 9 million seniors who currently pay as much as $6,497 in out-of-pocket costs per year for these prescriptions.
Medicines on the list include Merck & Co's diabetes drug Januvia, Eliquis rival Xarelto from Johnson & Johnson, and AbbVie's leukemia treatment Imbruvica.
Other drugs on the list include Amgen's rheumatoid arthritis drug Enbrel, Boehringer Ingelheim, Eli Lilly's diabetes drug Jardiance, J&J's arthritis and Crohn's disease Stelara, and insulin from Novo Nordisk.
#medicare #whitehouse
The New York Post is your source for breaking news, news about New York, sports, business, entertainment, opinion, real estate, culture, fashion, and more.
Subscribe to New York Post Sports
Catch the latest news here
Follow The New York Post on:
Sentinel Indexing in Progress
Metadata and chapters are available. Claim extraction for this episode is pending.
All video content is delivered via YouTube embedded players in accordance with the YouTube Terms of Service. Sentinel provides research tools that promote discovery and accountability across political media.
